Schering-Plough Teams Up With Huya To Identify Novel Compounds In China
This article was originally published in PharmAsia News
Executive Summary
Schering-Plough susbsidiary Organon and Huya Bioscience International unveiled an agreement Dec. 15 under which Huya will identify and present to Organon drug candidate compounds originating in China for specific therapeutic areas